Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2020-A00321-38 | Other Identifier | ANSM |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
An inflammatory state of the nasal cells (very close to keratinocytes) could favour the internalization of Staphylococcus aureus and thus constitute a persistent reservoir for the carriage of this bacterium.
Staphylococcus aureus is a commensal bacterium of the skin and mucous membranes that colonizes approximately 2 billion people worldwide Staphylococcus aureus is also a leading cause of community and healthcare-associated infection. Staphylococcus aureus has demonstrated its ability to invade many non-professional phagocytic cell lines such as keratinocytes, osteoblasts, fibroblasts, epithelial cells and endothelial cells. During pro-inflammatory stimulation, internalization of Staphylococcus aureus into keratinocytes is mainly mediated by ICAM-1. These results suggest that, in humans, an inflammatory state of the nasal cells (very close to keratinocytes) could promote the internalization of Staphylococcus aureus and thus constitute a persistent reservoir for the carriage of this bacterium.
The main objective is to compare the expression level of ICAM-1 in nasal cells with and without the presence of Staphylococcus aureus.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Healthy volunteers | Experimental | Healthy volunteers will be included. They will have nasal swab at the inclusion visit to detect contamination of S. Aureus.
|
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| nasal swab | Diagnostic Test | nasal swab will be performed to analysis biological markers at every visit. |
|
| Measure | Description | Time Frame |
|---|---|---|
| level of ICAM-1 expression in nasal cells | Compare the level of ICAM-1 expression in nasal cells with and without the presence of intracellular Staphylococcus aureus | Months: 0 |
| Measure | Description | Time Frame |
|---|---|---|
| Measurement of the expression of the genes (mRNA dosage) involved in IL-1 beta secretion | Measure by rt-qPCR technique. | Months: 0 |
| Measurement of the expression of the genes (mRNA dosage) involved in activation of autophagy |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Paul Verhoeven, MD | Centre Hospitalier Universitaire de Saint Etienne | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHU de Saint-Etienne | Saint-Etienne | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D013203 | Staphylococcal Infections |
| ID | Term |
|---|---|
| D016908 | Gram-Positive Bacterial Infections |
| D001424 | Bacterial Infections |
| D001423 | Bacterial Infections and Mycoses |
| D007239 | Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Measure by rt-qPCR technique.
| Months: 0 |
| cytokine concentration | Measure by analysis of nasal swab. | Months: 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 |
| concentration of ICAM-1 in S. Aureus | Measure by analysis of nasal swab. | Months: 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 |